Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Mirkin
Sebastian
S
The Contraceptive Research and Development Program, Clinical Research Center, The Jones Institute for Reproductive Medicine. Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, VA 23507, USA.
Archer
David F
DF
D000230:Adenocarcinoma; D002460:Cell Line; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D016889:Endometrial Neoplasms; D004717:Endometrium / Q000187:drug effects*; D004847:Epithelial Cells; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D015870:Gene Expression / Q000187:drug effects*; D006727:Hormone Antagonists / Q000494:pharmacology; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage / Q000494:pharmacology*; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis*; D019700:Thrombospondin 1 / Q000235:genetics*; D014407:Tumor Cells, Cultured; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics*
D003280:Contraceptives, Oral, Synthetic; D006727:Hormone Antagonists; D012333:RNA, Messenger; D019700:Thrombospondin 1; D042461:Vascular Endothelial Growth Factor A; D015735:Mifepristone; D011374:Progesterone; D004958:Estradiol